Setting the standard for recovery: Physicians' Health Programs

Journal of Substance Abuse Treatment

Volumn 36, Issue 2, 2009, Pages 159-171

  DuPont, Robert L ^a   McLellan, A Thomas ^b   White, William L ^c   Merlo, Lisa J ^d   Gold, Mark S ^d  

^a Institute for Behavior and Health   (United States)

^b Treatment Research Institute   (United States)

^c CHESTNUT HEALTH SYSTEMS   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Addiction treatment; Physicians health programs; Substance use disorders

Indexed keywords

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; DRUG ABUSE; DRUG WITHDRAWAL; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HUMAN; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; ALCOHOLISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICES; PHYSICIAN IMPAIRMENT; RETROSPECTIVE STUDIES; SELF-HELP GROUPS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TEMPERANCE; TREATMENT OUTCOME;

EID: 58349092925     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2008.01.004     Document Type: Article

References (62)

1. Angres D., et al. Psychiatric comorbidity and physicians with substance use disorders: A comparison between the 1980s and 1990s. Journal of Addictive Diseases 22 (2003) 79-87
2. Belenko S.B., DeMatteo D.S., and Patapis N.S. Drug courts. In: Roberts A.R., and Springer D.W. (Eds). Forensic social work in juvenile and criminal justice: An evidence-based handbook (2007), Charles C. Thomas Pub., Ltd, Springfield, IL 256-281
3. Bennet J., and O'Donovan D. Substance misuse by doctors, nurses and other healthcare workers. Current Opinion in Psychiatry 14 (2001) 195-199
4. Betty Ford Center in the News. Focused continuing care: One-year, extended care at Betty Ford Center. Retrieved from (2006). http://www.bettyfordcenter.org/news/innews/narticle.php?id=16
5. Betty Ford Institute Consensus Panel. What is recovery? A working definition from the Betty Ford Institute. Journal of Substance Abuse Treatment 36 (2007) 413-423
6. Bogenschutz M.P., Tonigan J.S., and Miller W.R. Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change. Journal of Studies on Alcohol 67 (2006) 562-567
7. Bruins M.R., Okano C.K., Lyons T.P., and Lukey B.J. Drug-positive rates for the Army from fiscal years 1991 to 2000 and for the National Guard from fiscal years 1997 to 2000. Military Medicine 167 (2002) 379-383
8. Chambers R., and Belcher J. Self-reported health care over the past 10 years: A survey of general practitioners. British Journal of General Practice 42 (1992) 153-156
9. Christie J., Rosen I., Bellini L., et al. Prescription drug use and self-prescription among resident physicians. Journal of the American Medical Association 280 (1998) 1253-1255
10. Conrad S.E., Hughes P.H., Baldwin D.C., et al. Substance use by fourth-year students at 13 U.S. medical schools. Journal of Medical Education 63 (1988) 747-758
11. Dennis M.L., Scott C.K., and Funk R. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Evaluation and Program Planning 26 (2003) 339-352
12. Domino K.B., Hornbein T.F., Polissar N.L., Renner G., Johnson J., Alberti S., and Hankes L. Risk factors for relapse in health care professionals with substance use disorders. Journal of the American Medical Association 293 (2005) 1453-1460
13. DuPont R.L. Biology and the environment: Rethinking demand reduction. Journal of Addictive Diseases 18 (1999) 121-138
14. Farber N.J., et al. Physician's willingness to report impaired colleagues. Social Science & Medicine 61 (2005) 1772-1775
15. Festinger D.S., Marlowe D.B., Lee P.A., Kirby K.C., Bovasso G., and McLellan A.T. Status hearings in drug court: When more is less and less is more. Drug and Alcohol Dependence 68 (2002) 151-157
16. Fiorentine R., and Hillhouse M. Drug treatment and 12-step program participation: The additive effects of integrated recovery activities. Journal of Substance Abuse Treatment 18 (2000) 65-74
17. Flaherty J.A., and Richman J.A. Substance use and addiction among medical students, residents, and physicians. Psychiatric Clinics of North America 16 (1993) 189-197
18. Fowlie D.G. Doctors' drinking and fitness to practice. Alcohol and Alcoholism 40 (2005) 483-484
19. Galanter M., et al. Combined Alcoholics Anonymous and professional care for addicted physicians. American Journal of Psychiatry 147 (1990) 64-68
20. Gallegos K.V., Lubin B.H., Bowers C., et al. Relapse and recovery: Five to ten year follow-up study of chemically-dependent physicians. The Georgia experience. Maryland Medical Journal 41 (1992) 315-319
21. Gastfriend D.R. Physician substance abuse and recovery: What does it mean for physicians-and everyone else?. Journal of the American Medical Association 293 (2005) 1513-1515
22. Gold M.S., and Aronson M.D. Treatment of Alcohol Abuse and Dependence (2004), Harvard University UpToDate, Cambridge, MA (CD ROM educational program)
23. Gold M.S., and Aronson M. Physician health and impairment. Psychiatric Annals 34 (2005) 736-740
24. Gold M.S., Extein I., Perzel J., and Annitto W.J. Naltrexone in the treatment of physician addicts. American Psychiatric Association 95 (1982) 275
25. Gold M.S., Pomm R., Kennedy Y., Jacobs W., and Frost-Pineda K. 5-Year state-wide study of physician addiction treatment outcomes confirmed by urine testing (2002), Society for Neuroscience, Orlando, FL
26. Hazelden to launch unique continuing care program. Retrieved from (2007). http://www.hazelden.org/web/public/vcsum5contcare.page
27. Hubbard R.L., Flynn P.M., Craddock G., and Fletcher B. Relapse after drug abuse treatment. In: Tims F., Leukfield C., and Platt J. (Eds). Relapse and Recovery in Addictions (2001), Yale University Press, New Haven 109-121
28. Hughes P.H., Brandenburg N., Baldwin D.C., et al. Prevalence of substance use among US Physicians. Journal of the American Medical Association 267 (1992) 2333-2339
29. Institute of Medicine. Improving the quality of health care for mental and substance-use conditions (2006), National Academy Press, Washington, DC
30. Jacobs W.S., Hall J.D., Pomm R., et al. Prognostic factors for physician addiction outcomes at five years. American Society of Addiction Medicine Annual Medical-Scientific Meeting; 2004 April 24; Washington DC (2004)
31. Jacobs W.S., Repetto M., Vinson S., Pomm R., and Gold M.S. Random urine testing as an intervention for drug addiction. Psychiatric Annals 34 (2004) 781-784
32. Kintz P., Villain M., Dumestre V., and Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Science International 153 (2005) 81-84
33. Kliner D., Spicer J., and Barnett P. Treatment outcome of alcoholic physicians. Journal of Studies on Alcohol 41 (1980) 1217-1219
34. Koenig L., Denmead G., Nguyen R., Harrison M., and Harwood H. The Costs and Benefits of Substance Abuse Treatment. NTIES. National Treatment Improvement Evaluation Study. Final Report. Substance Abuse and Mental Health Services Administration (1997)
35. Lloyd G. One hundred alcoholic doctors: A 21-year follow-up. Alcohol and Alcoholism 37 (2002) 370-374
36. Manchikanti L., Manchukonda R., Pampati V., Damron K.S., Brandon D.E., Cash K.A., and McManus C.D. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?. Pain Physician 9 (2006) 123-129
37. Marlowe D.B., and Wong C.J. Contingency management in adult criminal drug courts. In: Higgins S.T., Silverman K., and Heil S.H. (Eds). Contingency management in substance abuse treatment (2007), Guilford Press, New York 334-354
38. Mechanic D., Schlesinger M., and McAlpine D. Management of mental health and substance abuse Services: State of the art and early results the Milbank Quarterly Vol. 73, No. 1 (1995) 19-55
39. McGovern M.P., Angres D.H., and Leon S. Differential therapeutics and the impaired physician: Patient-treatment matching by specificity and intensity. Journal of Addictive Diseases 17 (1998) 93-107
40. McKay J.R., Lynch K.G., Shephard D.S., and Pettinati H.M. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence. Archives of General Psychiatry 62 (2005) 199-207
41. McLellan A.T., Kleber H.D., and Carise D. The national addiction treatment infrastructure: Can it support the public's demand for quality care?. Journal of Substance Abuse Treatment 25 (2003) 117-121
42. Merlo L.J., and Gold M.S. Elements of successful treatment programs for physicians with addictions. Psychiatric Times 14 (2008) 76-81
43. Merlo L.J., and Gold M.S. Prescription opioid abuse and dependence among physicians: Hypotheses and treatment. Harvard Review of Psychiatry 16 (2008) 181-194
44. Monahan G. Drug use/misuse among health professionals. Substance Use & Misuse 38 (2003) 1877-1881
45. Moos R.H., and Moos B.S. Paths of entry in to Alcoholics Anonymous: Consequences for participation and remission. Alcoholism, Clinical and Experimental Research 29 (2005) 1858-1868
46. Musto D. The American disease: Origins of narcotic control. 3rd ed. (1999), Oxford University Press, Oxford
47. Nace E.P., Birkmayer F., Sullivan M.A., et al. Socially sanctioned coercion mechanisms for addiction treatment. American Journal of Addictions 16 (2007) 15-23 10.1080/10550490601077783
48. Newcomb M.D. Substance abuse and control in the United States: Ethical and legal issues. Social Science & Medicine 35 (1992) 471-479
49. Osterloh J.D., and Becker C.E. Chemical dependency and drug testing in the workplace. Journal of Psychoactive Drugs 22 (1990) 407-417
50. Pomm R.M., and Harmon L. Evaluation and posttreatment monitoring of the impaired physician. Psychiatric Annals 34 (2004) 786-789
51. Roy A. Suicide in doctors. Psychiatric Clinics of North America 8 (1985) 377-387
52. Shore J. The Oregon experience with impaired physicians on probation: An eight year follow-up. Journal of the American Medical Association 257 (1987) 2931-2934
53. Simon W. Suicide among physicians: Prevention and postvention. Crisis 7 (1986) 1-13
54. Simpson D., and Joe G. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 30 (1993) 357-368
55. Skipper G.E., Weinmann W., Thierauf A., et al. Ethyl glucoronide: A biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol and Alcoholism 39 (2004) 445-449 10.1093/alcalc/agh078
56. Smith P.C., and Smith J.D. Treatment outcomes of impaired physicians in Oklahoma. Journal - Oklahoma State Medical Association. 84 (1991) 599-603
57. Talbott G., Gallegos K., Wilson P., and Porter T. The Medical Association of Georgia's impaired physicians' program: Review of the first 1000 physicians-Analysis of specialty. Journal of the American Medical Association 257 (1987) 2927-2930
58. Van den Brink W., and Haasen C. Evidenced-based treatment of opioid-dependent patients. Canadian Journal of Psychiatry 51 (2006) 635-646
59. Washton A.M., Gold M.S., and Pottash A.C. Successful use of naltrexone in addicted physicians and business executives. Advances in Alcohol & Substance Abuse 4 (1984) 89-96
60. White W. Listening to history: Lessons for the EAP/managed care field. EAP Digest 20 (2000) 16-26
61. White W. Slaying the dragon: The history of addiction treatment and recovery in America (1998), Chestnut Health Systems, Bloomington, IL
62. White W.L., DuPont R.L., and Skipper G.E. Physicians Health Programs: What counselors can learn from these remarkable programs. Counselor 8 (2007) 42-47